Rockey N, et al. Challenging health inequities in incarceration: A call for equitable care for kidney disease and hypertension. Curr Hypertens Rep 2023; 25:437–445. doi: 10.1007/s11906-023-01267-z
Maruschak LM, et al. Medical problems of state and federal prisoners and jail inmates, 2011–12. Department U.S. of Justice, Office of Justice Programs. Bureau of Justice Statistics, February 2015; pp. 1–22. Revised October 4, 2016. Accessed December 4, 2021. https://bjs.ojp.gov/content/pub/pdf/mpsfpji1112.pdf
Widra E, Herring T. States of incarceration: The global context 2021. Prison Policy Initiative. September 2021. https://www.prisonpolicy.org/global/2021.html
Curran J, et al. Estimated use of prescription medications among individuals incarcerated in jails and state prisons in the US. JAMA Health Forum 2023; 4:e230482. doi: 10.1001/jamahealthforum.2023.0482
Panesar M, et al. Evaluation of a renal transplant program for incarcerated ESRD patients. J Correct Health Care 2014; 20:220–227. doi: 10.1177/1078345814531726
Shavit S, et al. Transitions Clinic Network: Challenges and lessons in primary care for people released from prison. Health Aff (Millwood) 2017; 36:1006–1015. doi: 10.1377/hlthaff.2017.0089
The following article is the third of a five-issue series focused on caring for patients in underserved populations. Inspired by several sessions at Kidney Week 2023, this series features unique patient and physician perspectives, explains legal protections and limitations, and seeks to identify opportunities to improve kidney care for these communities.